Drug Profile
Research programme: cardiovascular disorders therapy - Medicago
Alternative Names: Cardiovascular vaccine - Acambis/Medicago; MED-201; MED-202; MED-205Latest Information Update: 15 Feb 2008
Price :
$50
*
At a glance
- Originator Medicago
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders; Hypercholesterolaemia